News & Views

From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.

Read more
Show me:

All News and views

Research and new developments

Healthy living and emotional wellbeing

Policy and campaigning news

Getting involved

Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk